Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Kenner

Showing results (71-80 of 267) with videos related to

Pageof 27
Sort By:
Plos One|July 12, 2014
Reliable quantification of protein expression and cellular localization in histological sectionsMichaela Schlederer, Kristina M Mueller, Johannes Haybaeck, et al.
Nature Genetics|May 1, 2007
p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathwayLijian Hui, Latifa Bakiri, Andreas Mairhorfer, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|February 13, 2019
Pretreatment assessment of hematologic and inflammatory markers in adenoid cystic carcinoma: neutrophil/lymphocyte ratio is associated with multiple recurrencesFaris F Brkic, Lorenz Kadletz, Bernhard Jank, et al.
Allergy|March 8, 2020
NSG mice humanized with allergen-specific T-cell lines as in vivo model of respiratory allergyCaterina Vizzardelli, Felix Zimmann, Birgit Nagl, et al.
Diabetologia|November 19, 2016
Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in miceDoris Kaltenecker, Kristina M Mueller, Pia Benedikt, et al.
Nature|September 16, 2005
Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteinsRainer Zenz, Robert Eferl, Lukas Kenner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 21, 2023
Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate CancerKilian Kluge, David Haberl, Holger Einspieler, et al.
Molecular and Cellular Biology|April 29, 2015
Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III InterferonsIsabella Rauch, Felix Rosebrock, Eva Hainzl, et al.
Scientific Reports|March 8, 2017
Absence of PD-L1 on tumor cells is associated with reduced MHC I expression and PD-L1 expression increases in recurrent serous ovarian cancerStefanie Aust, Sophie Felix, Katharina Auer, et al.
Cytokine|June 29, 2016
JAK-STAT signaling in cancer: From cytokines to non-coding genomeJan Pencik, Ha Thi Thanh Pham, Johannes Schmoellerl, et al.
Pageof 27

Showing results (71-80 of 267) with videos related to

Sort By:
Pageof 27
Plos One|July 12, 2014
Reliable quantification of protein expression and cellular localization in histological sectionsMichaela Schlederer, Kristina M Mueller, Johannes Haybaeck, et al.
Nature Genetics|May 1, 2007
p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathwayLijian Hui, Latifa Bakiri, Andreas Mairhorfer, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|February 13, 2019
Pretreatment assessment of hematologic and inflammatory markers in adenoid cystic carcinoma: neutrophil/lymphocyte ratio is associated with multiple recurrencesFaris F Brkic, Lorenz Kadletz, Bernhard Jank, et al.
Allergy|March 8, 2020
NSG mice humanized with allergen-specific T-cell lines as in vivo model of respiratory allergyCaterina Vizzardelli, Felix Zimmann, Birgit Nagl, et al.
Diabetologia|November 19, 2016
Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in miceDoris Kaltenecker, Kristina M Mueller, Pia Benedikt, et al.
Nature|September 16, 2005
Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteinsRainer Zenz, Robert Eferl, Lukas Kenner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 21, 2023
Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate CancerKilian Kluge, David Haberl, Holger Einspieler, et al.
Molecular and Cellular Biology|April 29, 2015
Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III InterferonsIsabella Rauch, Felix Rosebrock, Eva Hainzl, et al.
Scientific Reports|March 8, 2017
Absence of PD-L1 on tumor cells is associated with reduced MHC I expression and PD-L1 expression increases in recurrent serous ovarian cancerStefanie Aust, Sophie Felix, Katharina Auer, et al.
Cytokine|June 29, 2016
JAK-STAT signaling in cancer: From cytokines to non-coding genomeJan Pencik, Ha Thi Thanh Pham, Johannes Schmoellerl, et al.
Pageof 27